Project Grant HT94252510542
Award Date
9/1/25
Completion Date
8/31/29
Dollars Obligated
$676K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
This $2,131,863 federal Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research at the University of Oklahoma Health Sciences Center to investigate expanded GAA-GGA chimeric repeats in Friedreich ataxia. The research aims to transform healthcare for military service members, veterans, and the public by addressing critical health challenges related to this genetic disorder. The 4-year...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $326,712.00 to The Children's Hospital of Philadelphia Research Institute to conduct a structured lipid nutrition intervention study on symptom management and quality of life. The research will take place from September 1, 2025 to August 31, 2027. The Military Medical Research and Development program supports advanced biomedical research to transform...
The U.S. Defense Health Agency awarded a $777,659 Project Grant to the Children's Research Institute in Washington, D.C. under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research to transform healthcare for military service members, veterans, and the public, with a focus on innovative research addressing critical health challenges. Specifically, the award will fund the "Use of ProResolution and Restorative Pharmacology...
This Project Grant award from the Department of Defense's Defense Health Agency provides $313,000.00 to the University of Massachusetts Lowell to conduct research on how small and weak muscles develop in Friedreich's ataxia patients. The research aims to improve understanding of this neurological disorder that affects service members and veterans. The award is funded under the Military Medical Research and Development CFDA program (12.420), which supports a range of biomedical research to...
This $240,897 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, will support integrative transcriptomic and epigenomic profiling of subependymal giant cell astrocytoma at single-cell resolution. The award was made to Duke University's Office of Research Administration on August 1, 2025, with a period of performance through July 31, 2027. The Military Medical Research and Development program funds advanced biomedical...
The U.S. Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $1,984,636 Project Grant to The Children's Hospital of Philadelphia (CHOP) to conduct research on identifying and reversing functional cerebellar circuit dysfunctions in Friedreich's ataxia mice. The grant, awarded on September 1, 2024, will support this research project over a 4-year period until August 31, 2028. As a leading pediatric research institution, CHOP will leverage...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $934,501 project grant to The Children's Hospital of Philadelphia Research Institute. The grant, titled "Developing Peptide-Centric CARs for NF1-Associated MPNST", will fund advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The research aims to develop innovative peptide-based chimeric antigen receptor (CAR) therapies...
This federal Project Grant award for $1,178,136.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by the University of Pennsylvania to exploit the absence of TP53 mutations in epithelial ovarian cancer using next-generation p53-stabilizing agents. The award has a performance period from April 15, 2025 to April 19, 2029 and aims to transform healthcare for military service members, veterans, and the broader...
The Children's Hospital of Philadelphia (CHOP) has been awarded a $1,773,720.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420) by the Defense Health Agency. This award, with a period of performance from July 1, 2024 to June 30, 2028, will support research to elucidate the cardiomyopathy associated with the mitochondrial disorder Friedreich's ataxia. CHOP, a leading pediatric hospital and research facility, will leverage its expertise in areas like genetic...
The federal Project Grant award ID HT94252510342, totaling $405,341.00, was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The award supports the use of proresolution and restorative pharmacology approaches for Duchenne muscular dystrophy (DMD) therapy at the Children's Research Institute, a non-profit pediatric research organization in Washington, D.C. The award will fund advanced biomedical research and development focused...